We are live on
!
Find out more
Parallel Advisors Portfolio holdings
AUM
$6.56B
Turnover
11.49%
1-Year Est. Return
32.24%
This Fund
S&P 500
This Quarter
Est. Return
+8.88%
1 Year Est. Return
+32.24%
3 Year Est. Return
+108.68%
5 Year Est. Return
+114.41%
10 Year Est. Return
–
AUM
$5B
AUM Growth
+$569M
(+13%)
Cap. Flow
+$104M
Cap. Flow
% of AUM
2.08%
Top 10 Holdings %
Top 10 Hldgs %
38.84%
Holding
3,762
New
251
Increased
1,450
Reduced
1,277
Closed
224
Avg Time Held Equity + Options
4.7
years
Top 10 Avg Time Held Equity + Options
2.9
years
Top 20 Avg Time Held Equity + Options
3.8
years
Avg Time Held Equity only
4.7
years
Top 10 Avg Time Held Equity only
2.9
years
Top 20 Avg Time Held Equity only
3.8
years
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Core S&P 500 ETF
IVV
|
+$18.4M |
| 2 |
iShares Core S&P Total US Stock Market ETF
ITOT
|
+$9.77M |
| 3 |
BlackRock US Equity Factor Rotation ETF
DYNF
|
+$5.48M |
| 4 |
Microsoft
MSFT
|
+$4.93M |
| 5 |
Vanguard S&P 500 ETF
VOO
|
+$4.9M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Corcept Therapeutics
CORT
|
+$7.34M |
| 2 |
Starbucks
SBUX
|
+$4.7M |
| 3 |
iShares California Muni Bond ETF
CMF
|
+$3.3M |
| 4 |
Invesco S&P 500 Equal Weight ETF
RSP
|
+$2.63M |
| 5 |
Vanguard Morningstar Small-Cap ETF
VB
|
+$1.7M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 46.71% |
| 2 | Technology | 17.21% |
| 3 | Healthcare | 9.68% |
| 4 | Financials | 7.2% |
| 5 | Communication Services | 5.16% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
3451
Cohen & Steers REIT and Preferred and Income Fund
RNP
$885M
| $68 | ﹤0.01% |
3
| – | – |
2020 Q4
18 quarters
|
|
3452
GoodRx Holdings
GDRX
$1.19B
| $65 | ﹤0.01% |
13
-86
| -87% | -$374 |
2023 Q4
6 quarters
|
|
|
ADAP
3453
DELISTED
Adaptimmune Therapeutics
ADAP
| $60 | ﹤0.01% |
250
| – | – |
2024 Q2
4 quarters
|
|
3454
IBEX
IBEX
$610M
| $58 | ﹤0.01% |
2
-13
| -87% | -$348 |
2025 Q1
1 quarter
|
|
3455
Rackspace Technology
RXT
$813M
| $58 | ﹤0.01% |
+45
| New | +$59 |
2025 Q2
0 quarters
|
|
3456
AdvisorShares Pure Cannabis ETF
YOLO
$30.3M
| $57 | ﹤0.01% |
30
| – | – |
2023 Q1
9 quarters
|
|
3457
Vishay Precision Group
VPG
$853M
| $56 | ﹤0.01% |
2
| – | – |
2016 Q4
34 quarters
|
|
3458
Seaport Entertainment Group
SEG
$289M
| $56 | ﹤0.01% |
3
-9
| -75% | -$173 |
2024 Q3
3 quarters
|
|
3459
American Battery Technology Co
ABAT
$224M
| $55 | ﹤0.01% |
+34
| New | +$44 |
2025 Q2
0 quarters
|
|
3460
Elme Communities
ELME
$156M
| $55 | ﹤0.01% |
3
-3
| -50% | -$48 |
2023 Q2
8 quarters
|
|
3461
State Street SPDR S&P Software & Services ETF
XSW
$481M
| – | – |
0
| – | – |
2025 Q1
1 quarter
|
|
3462
Alpha and Omega Semiconductor
AOSL
$707M
| $51 | ﹤0.01% |
+2
| New | +$43 |
2025 Q2
0 quarters
|
|
3463
Invesco WilderHill Clean Energy ETF
PBW
$304M
| $50 | ﹤0.01% |
3
-79
| -96% | -$1.36K |
2023 Q4
6 quarters
|
|
3464
Tevogen Inc
TVGN
$46.1M
| $50 | ﹤0.01% |
+1
| New | +$57 |
2025 Q2
0 quarters
|
|
3465
Braemar Hotels & Resorts
BHR
$95.5M
| $49 | ﹤0.01% |
20
-136
| -87% | -$298 |
2022 Q4
10 quarters
|
|
3466
GeneDx Holdings
WGS
$2.09B
| $49 | ﹤0.01% |
+1
| New | +$79 |
2025 Q2
0 quarters
|
|
3467
ProShares VIX Short-Term Futures ETF
VIXY
$222M
| $47 | ﹤0.01% |
1
| – | – |
2022 Q2
12 quarters
|
|
3468
Consensus Cloud Solutions
CCSI
$679M
| $46 | ﹤0.01% |
2
-14
| -88% | -$302 |
2021 Q4
14 quarters
|
|
3469
Standard BioTools
LAB
$258M
| $44 | ﹤0.01% |
37
| – | – |
2024 Q1
5 quarters
|
|
3470
Organigram Holdings
OGI
$134M
| $43 | ﹤0.01% |
+32
| New | +$39 |
2025 Q2
0 quarters
|
|
3471
Empire State Realty Trust
ESRT
$819M
| $40 | ﹤0.01% |
5
| – | – |
2020 Q1
21 quarters
|
|
|
QVCGA
3472
DELISTED
QVC Group Inc Series A
QVCGA
| $39 | ﹤0.01% |
+14
| New | +$81 |
2025 Q2
0 quarters
|
|
3473
Oatly Group
OTLY
$356M
| $36 | ﹤0.01% |
3
| – | – |
2024 Q3
3 quarters
|
|
3474
Plug Power
PLUG
$2.08B
| $36 | ﹤0.01% |
24
-7,339
| -100% | -$7.32K |
2020 Q4
18 quarters
|
|
3475
Cartesian Therapeutics
RNAC
$199M
| $31 | ﹤0.01% |
103
+100
| +3,333% | +$1.06K |
2020 Q4
18 quarters
|
|
Similar funds
Parallel Advisors's Q2 2025 Portfolio in Review
As of Q2 2025, Parallel Advisors held 3,762 positions worth $5B, up 13% from $4.43B the previous quarter. Its ten largest holdings account for 39% of the portfolio.
Parallel Advisors's Q2 2025 filing shows 251 new, 1,450 increased, 1,277 reduced and 224 closed positions. Its largest new stake was Vanguard 0-3 Month Treasury Bill ETF: 32,722 shares worth $2.47M. The largest sale was Corcept Therapeutics, an estimated $7.34M.
By sector, the portfolio is most concentrated in Miscellaneous at 47% of assets, down from 47% a quarter earlier, followed by Technology and Healthcare.
- Parallel Advisors's largest Q2 2025 buy was Vanguard 0-3 Month Treasury Bill ETF: 32,722 shares worth $2.47M.
- Parallel Advisors added most to iShares Core S&P 500 ETF in Q2 2025, an estimated $18.4M increase.
- Parallel Advisors's biggest Q2 2025 reduction was Corcept Therapeutics, cutting an estimated $7.34M.
- Parallel Advisors fully exited Discover Financial Services in Q2 2025, selling an estimated $1.22M.
- Parallel Advisors's ten largest holdings make up 39% of its $5B portfolio in Q2 2025.
- Parallel Advisors opened 251 new positions and closed 224 in Q2 2025.
- Parallel Advisors's portfolio value rose 13% quarter-over-quarter to $5B.
Based on Parallel Advisors's 13F filing for Q2 2025, filed 8 Jul 2025.